University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Scarlett Gomez, MPH, PhD

Scarlett Gomez, MPH, PhD

Professor, Department of Epidemiology and Biostatistics, UCSF

Cancer Center Program Memberships

Cancer Control

Research Summary

Dr. Scarlett Lin Gomez is an epidemiologist with research interests in the role of social determinants of health, including race/ethnicity, socioeconomic status, gender, immigration status, sociocultural factors, and neighborhood contextual characteristics, on health outcomes. She is also Director of the Greater Bay Area Cancer Registry, a part of the California Cancer Registry and the NCI Surveillance Epidemiology End Results (SEER) Program. She has contributed surveillance data regarding cancer incidence and outcome patterns and trends for distinct Asian American, Native Hawaiian, and Pacific Islander and Hispanic ethnic groups, as well as cancer patterns by nativity status and neighborhood characteristics. She developed the California Neighborhoods Data System, a compilation of small-area level data on social and built environment characteristics, and has used these data in more than a dozen funded studies to evaluate the impact of social and built neighborhood environment factors on disease outcomes.

Education

  • University of California, Berkeley, CA B.A. 06/94 Biochemistry and Molecular Biology
  • University of Michigan, Ann Arbor, MI M.P.H. 06/97 Epidemiology
  • Stanford University, Stanford, CA Ph.D. 12/02 Epidemiology

Professional Experience

  • 1994-1996
    Chemist, Department of Metabolism, Bioanalysis and Pharmacokinetics, Roche Bioscience, Palo Alto, CA
  • 1996-1997
    Graduate Research Assistant, Department of Hospital Epidemiology and Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI
  • 1997-2000
    Res Asst (1997), Res Assoc (1998-2000), Department of Epidemiology and Biostatistics, School of Medicine, UCSF
  • 1997-2003
    Intern (1997), Res Asst (1998), Epidemiologist (1999-2003), Northern California Cancer Center (NCCC), Union City, CA
  • 2003-2009
    Research Scientist I (2003-4), Research Scientist II (2004-9), NCCC, Fremont, CA
  • 2004-2007
    Lecturer, Division of Epidemiology, Department of Health Research and Policy, School of Medicine, Stanford University, Stanford, CA
  • 2006-2010
    Associate Director, Surveillance Research, Greater Bay Area Cancer Registry, NCCC, Fremont, CA
  • 2007-2010
    Consulting Assistant Professor, Division of Epidemiology, Department of Health Research and Policy, School of Medicine, Stanford University, Stanford, CA
  • 2009-current
    Research Scientist III, Cancer Prevention Institute of California, Fremont, CA
  • 2010-2016
    Consulting Associate Professor, Division of Epidemiology, Department of Health Research and Policy, School of Medicine, Stanford University, Stanford, CA
  • 2016-current
    Director, Greater Bay Area Cancer Registry, CPIC, Fremont, CA
  • 2017-current
    Professor, Department of Epidemiology and Biostatistics, University of California, San Francisco, CA

Honors & Awards

  • 1996-1997
    Departmental Scholarship, School of Public Health, University of Michigan, Ann Arbor, MI

  • 1997
    Student Oncology Grant, American Cancer Society, California Division, Oakland, CA

  • 2000
    Scholarship, 7th Biennial Symposium on Minorities, the Medically Underserved & Cancer

  • 1998-2002
    Pre-Doctoral Cancer Training Grant, NCI (awarded to Stanford University, Stanford, CA)

  • 2007
    Selected participant, NCI Minority Investigators Workshop on Behavioral Methodologies

  • 2010
    Author of the Year, American Journal of Public Health

  • 2012
    Above and Beyond Excellence Award, Cancer Prevention Institute of California

  • 2014
    Mentoring Award, Cancer Prevention Institute of California

Selected Publications

  1. Martínez ME, Gomez SL, Tao L, Cress R, Rodriguez D, Unkart J, Schwab R, Nodora JN, Cook L, Komenaka I, Li C. Erratum to: Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. Breast Cancer Res Treat. 2017 Sep 04.
    View on PubMed
  2. Lin CY, Carneal EE, Lichtensztajn DY, Gomez SL, Clarke CA, Jensen KC, Kurian AW, Allison KH. Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks. Am J Clin Pathol. 2017 Sep 01; 148(3):199-207.
    View on PubMed
  3. Wapnir IL, Kurian AW, Lichtensztajn DY, Clarke CA, Gomez SL. Rising Bilateral Mastectomy Rates Among Neoadjuvant Chemotherapy Recipients in California From 1998 to 2012. Ann Surg. 2017 Aug; 266(2):353-360.
    View on PubMed
  4. Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncol. 2017 Sep 10; 35(26):3075-3082.
    View on PubMed
  5. Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. CA Cancer J Clin. 2017 Sep; 67(5):353-361.
    View on PubMed
  6. Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED. Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. Cancer Res. 2017 Sep 01; 77(17):4548-4555.
    View on PubMed
  7. Pinheiro PS, Callahan KE, Gomez SL, Marcos-Gragera R, Cobb TR, Roca-Barcelo A, Ramirez AG. High cancer mortality for US-born Latinos: evidence from California and Texas. BMC Cancer. 2017 Jul 11; 17(1):478.
    View on PubMed
  8. Martínez ME, Gomez SL, Tao L, Cress R, Rodriguez D, Unkart J, Schwab R, Nodora JN, Cook L, Komenaka I, Li C. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. Breast Cancer Res Treat. 2017 Jul 11.
    View on PubMed
  9. Han SS, Rivera GA, Tammemägi MC, Plevritis SK, Gomez SL, Cheng I, Wakelee HA. Risk Stratification for Second Primary Lung Cancer. J Clin Oncol. 2017 Sep 01; 35(25):2893-2899.
    View on PubMed
  10. McLaughlin RH, Gomez SL, Deapen D, Induni M. Human Subjects Protection and Cancer Surveillance Research: Revised Regulations, Expanded Opportunities. Cancer Res. 2017 Jun 15; 77(12):3140-3143.
    View on PubMed
  11. Martínez ME, Unkart JT, Tao L, Kroenke CH, Schwab R, Komenaka I, Gomez SL. Prognostic significance of marital status in breast cancer survival: A population-based study. PLoS One. 2017; 12(5):e0175515.
    View on PubMed
  12. Low YS, Daugherty AC, Schroeder EA, Chen W, Seto T, Weber S, Lim M, Hastie T, Mathur M, Desai M, Farrington C, Radin AA, Sirota M, Kenkare P, Thompson CA, Yu PP, Gomez SL, Sledge GW, Kurian AW, Shah NH. Synergistic drug combinations from electronic health records and gene expression. J Am Med Inform Assoc. 2017 May 01; 24(3):565-576.
    View on PubMed
  13. Gomez SL, Von Behren J, McKinley M, Clarke CA, Shariff-Marco S, Cheng I, Reynolds P, Glaser SL. Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes. Breast Cancer Res Treat. 2017 Jul; 164(1):139-147.
    View on PubMed
  14. Patel MI, McKinley M, Cheng I, Haile R, Wakelee H, Gomez SL. Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Lung Cancer. 2017 Jun; 108:140-149.
    View on PubMed
  15. Wang L, Gomez SL, Yasui Y. Racial and Ethnic Differences in Socioeconomic Position and Risk of Childhood Acute Lymphoblastic Leukemia. Am J Epidemiol. 2017 Mar 22; 1-9.
    View on PubMed
  16. Schootman M, Gomez SL, Henry KA, Paskett ED, Ellison GL, Oh A, Taplin SH, Tatalovich Z, Berrigan DA. Geospatial Approaches to Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev. 2017 Apr; 26(4):472-475.
    View on PubMed
  17. Pinheiro PS, Callahan KE, Siegel RL, Jin H, Morris CR, Trapido EJ, Gomez SL. Cancer Mortality in Hispanic Ethnic Groups. Cancer Epidemiol Biomarkers Prev. 2017 Mar; 26(3):376-382.
    View on PubMed
  18. Conroy SM, Shariff-Marco S, Koo J, Yang J, Keegan TH, Sangaramoorthy M, Hertz A, Nelson DO, Cockburn M, Satariano WA, Yen IH, Ponce NA, John EM, Gomez SL. Racial/Ethnic Differences in the Impact of Neighborhood Social and Built Environment on Breast Cancer Risk: The Neighborhoods and Breast Cancer Study. Cancer Epidemiol Biomarkers Prev. 2017 Apr; 26(4):541-552.
    View on PubMed
  19. Shariff-Marco S, Von Behren J, Reynolds P, Keegan TH, Hertz A, Kwan ML, Roh JM, Thomsen C, Kroenke CH, Ambrosone C, Kushi LH, Gomez SL. Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 Apr; 26(4):505-515.
    View on PubMed
  20. Conroy SM, Clarke CA, Yang J, Shariff-Marco S, Shvetsov YB, Park SY, Albright CL, Hertz A, Monroe KR, Kolonel LN, Marchand LL, Wilkens LR, Gomez SL, Cheng I. Contextual Impact of Neighborhood Obesogenic Factors on Postmenopausal Breast Cancer: The Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev. 2017 Apr; 26(4):480-489.
    View on PubMed

Go to UCSF Profiles, powered by CTSI